Research lines into Multiple Sclerosis

Reading time: 1 min

Multiple sclerosis is one of the neurological diseases in which the knowledge of it is more advanced, which makes it possible to establish an early and accurate diagnosis and develop new therapies.

In this sense, within a few years, there are now more than 10 treatments available, which due to their nature, have mainly contributed to decreasing the inflammatory activity of the disease and, in some cases, to decrease the progression of the disability in patients with the primary progressive form of the disease.

Efforts are now being made to have targeted therapies that could favour re-myelination or protect the nervous system from the neurodegenerative process inherent to this disease. Some of them are now being evaluated in clinical trials.

Cell therapies should not be forgotten, as they have the aim of re-adapting the malfunctioning immune system, nor the trials with stem cells to regenerate the established neurological deficits.

Similarly, various international projects are directed at identifying the factors involved in the heterogeneity of the disease, not only in the presentation and course of the disease, but also in the response to therapies. These projects use new tools such as advanced magnetic resonance, studies to identify genetic variants and biological markers in blood and cerebrospinal fluid, which may help to predict the prognosis in a more individualised way and personalise the treatment.

Substantiated information by:

Albert Saiz Hinarejos
Ana Hernando Andrés

Published: 20 February 2018
Updated: 20 February 2018


Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.